| 1 |
32426479 | RasGRP1 is a causal factor in the development of l-DOPA-induced dyskinesia in Parkinson's disease. | 2020 May |
3 |
| 2 |
29992529 | MTOR Pathway-Based Discovery of Genetic Susceptibility to L-DOPA-Induced Dyskinesia in Parkinson's Disease Patients. | 2019 Mar |
2 |
| 3 |
32146463 | Regulation of Protein Synthesis and Apoptosis in Lymphocytes of Parkinson Patients: The Effect of Dopaminergic Treatment. | 2019 |
1 |
| 4 |
24144882 | New genetic insights highlight 'old' ideas on motor dysfunction in dystonia. | 2013 Dec |
1 |
| 5 |
22179112 | Rhes, a striatal-enriched small G protein, mediates mTOR signaling and L-DOPA-induced dyskinesia. | 2011 Dec 18 |
2 |
| 6 |
19622830 | Thwarting dyskinesia by targeting mTORC1. | 2009 Jul 21 |
1 |
| 7 |
19622833 | Inhibition of mTOR signaling in Parkinson's disease prevents L-DOPA-induced dyskinesia. | 2009 Jul 21 |
2 |